Van Eck Associates Corp. »

Blueprint Medicines shares owned by Van Eck Associates Corp.

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Van Eck Associates Corp. from 13F filings

Historical chart of Van Eck Associates Corp. investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Van Eck Associates Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Van Eck Associates Corp.

Quarter filed Position value Share count Share price at filing
2025-09-30 $17k 132 128.79
2025-06-30 $129k 1.0k 128.49
2025-03-31 $99k 1.1k 88.71
2024-12-31 $97k 1.1k 86.92
2024-09-30 $64k 753 84.99
2024-06-30 $120k 1.1k 107.53
2024-03-31 $93k 985 94.42
2023-12-31 $80k 872 91.74
2023-09-30 $34k 679 50.07
2023-06-30 $43k 679 63.33
2023-03-31 $37k 825 44.85
2022-12-31 $43k 986 43.61
2022-09-30 $43k 652 65.95
2022-03-31 $99k 1.5k 63.95
2021-12-31 $143k 1.3k 107.12
2021-09-30 $119k 1.2k 102.67
2021-06-30 $64k 728 87.91
2021-03-31 $33k 336 98.21